Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,249 | -5,412 | -23,769 | -20,870 | -14,056 |
| Depreciation Amortization | 100 | 61 | 273 | 210 | 145 |
| Accounts receivable | -7 | 96 | -280 | -32 | -83 |
| Other Working Capital | 333 | 442 | -385 | 2,119 | 1,562 |
| Other Operating Activity | 1,015 | 578 | 2,828 | 2,052 | 1,444 |
| Operating Cash Flow | $-8,808 | $-4,235 | $-21,333 | $-16,521 | $-10,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 80 | 80 | -85 | -85 | -82 |
| Investing Cash Flow | $80 | $80 | $-85 | $-85 | $-82 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | 10,000 | 10,000 |
| Debt Repayment | -666 | -333 | N/A | 0 | N/A |
| Common Stock Issued | 13,098 | 13,085 | 586 | 567 | 267 |
| Other Financing Activity | -287 | -287 | -256 | -256 | -256 |
| Financing Cash Flow | $12,145 | $12,465 | $10,330 | $10,311 | $10,011 |
| Beginning Cash Position | 12,786 | 12,786 | 23,874 | 23,874 | 23,874 |
| End Cash Position | 16,203 | 21,096 | 12,786 | 17,579 | 22,815 |
| Net Cash Flow | $3,417 | $8,310 | $-11,088 | $-6,295 | $-1,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,808 | -4,235 | -21,333 | -16,521 | -10,988 |
| Capital Expenditure | N/A | N/A | -85 | -85 | -82 |
| Free Cash Flow | -8,808 | -4,235 | -21,418 | -16,606 | -11,070 |